Back to search
Pharmacokinetic Analysis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pharmacokinetic Analysis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pharmacokinetic Analysis trials you may qualify forCefiderocol is a powerful, broad spectrum antibiotic approved to treat hospital-acquired or ventilator associated pneumonia and urinary tract infections. Althou…
The goal of this double-blind, randomized, placebo-controlled parallel-group multicenter exploratory pilot study (three study arms) is to describe effects and s…
Based on an established Kawasaki disease cohort database, this prospective, single-center, single-arm, observational study will collect clinical data from child…
A multicenter, national, prospective, observational pharmacological study of patients with difficult-to-treat Gram-negative infections treated with ceftazidime/…
Rationale: Crohn's disease (CD) is a chronic, debilitating inflammatory bowel disease (IBD) which is diagnosed during childhood in up to one in ten patients. Th…
Buruli ulcer (BU) is a skin Neglected Tropical Disease (NTD) that is caused by Mycobacterium ulcerans. It affects skin, soft tissues and bones causing long-term…
The primary objective is to evaluate whether treatment with alpelisib in combination with fulvestrant prolongs Progression Free Survival (PFS) compared to treat…
A pharmacokinetics and pharmacogenetics study to complement the current knowledge of tacrolimus prolonged release (Advagraf®) in the immediate post-transplantat…
A three-part, randomized, double-blind study in healthy older adults to identify a dose of deupirfenidone for further clinical study.